Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Strepronin is a mucolytic drug. A mucolytic agent is any agent which dissolves thick mucus usually used to help relieve respiratory difficulties. The viscosity of mucous secretions in the lungs... The viscosity of mucous secretions in the lungs is dependent upon the concentrations of mucoprotein as well as the presence of disulfide bonds between these macromolecules and DNA.
- Mechanism
- Curator reviewed
An expectorant increases bronchial secretions and mucolytics help loosen thick bronchial secretions. Expectorants reduce the thickness or viscosity of bronchial secretions thus increasing mucus flow that can be removed more easily through coughing, Mucolytics break down the chemical structure of mucus molecules. The mucus becomes thinner and can be removed more easily through coughing.
- Primary indication
- Strepronin is a mucolytic (expectorant) drug.Curator reviewed
- Formula / weight
- C10H11NO4S2 · 273.329 g/mol (avg)
- Also known as
- Tiofacic
Resolves to
JNYSEDHQJCOWQU-UHFFFAOYSA-NSMILESCC(SC(=O)C1=CC=CS1)C(=O)NCC(O)=OWhat you can answer from here — as of September 23, 2026
Which companies are running trials of Stepronin, in which indications and phases, and which of those programs are still active?